Yixin Niu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yixin Niu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Qing Su
Department of Endocrine and Metabolic Diseases, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications - Zhen Yang
Department of Endocrinology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications Guang Ning
Shanghai Institute of Endocrinology and Metabolism, Department of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
1 shared publication- Hongmei Zhang
Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
1 shared publication - Hongmei Zhang
Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Shanghai, China
1 shared publication Hongxia Gu
Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
1 shared publication
Latest Publications
- 25 September 2023
- Published by Wiley in Psychology & Marketing
- Vol. 40 (12) , 2487-2503
“Unattractive = natural”: How explicit and implicit beliefs jointly affect consumer purchase of unattractive produce
To reduce the waste of aesthetically unappealing yet safe produce, marketers and policymakers have attempted to associate such produce with the concept of “naturalness” (i.e., establishing the “unattractive = natural” belief), thereby increasing its appeal to consumers. However, research findings conflict regarding the effectiveness of this approach. To reconcile these inconsistencies, the present research suggests that two types of “unattractive = natural” beliefs—explicit and implicit—collectively influence consumer purchase of unattractive produce. Through one field and two lab experiments using two methods to measure implicit beliefs (i.e., the Implicit Association Test and word‐embedding method) and consumer purchases (i.e., actual product choices and a Likert scale), we found that consumers with a high level of incongruence between explicit and implicit “unattractive = natural” beliefs exhibit a greater preference for unattractive produce than those with a low level of such incongruence. This occurs because the incongruence between implicit and explicit beliefs prompts elaborative thinking about the naturalness of unattractive produce, thus alleviating consumer avoidance. Our undertaking contributes to the existing literature on consumer purchase of unattractive produce by examining explicit and implicit beliefs. It also offers valuable insights into leveraging implicit measurement techniques to mitigate food waste.
- 25 September 2023
- Published by Wiley in Psychology & Marketing
- Vol. 40 (12) , 2487-2503
“Unattractive = natural”: How explicit and implicit beliefs jointly affect consumer purchase of unattractive produce
To reduce the waste of aesthetically unappealing yet safe produce, marketers and policymakers have attempted to associate such produce with the concept of “naturalness” (i.e., establishing the “unattractive = natural” belief), thereby increasing its appeal to consumers. However, research findings conflict regarding the effectiveness of this approach. To reconcile these inconsistencies, the present research suggests that two types of “unattractive = natural” beliefs—explicit and implicit—collectively influence consumer purchase of unattractive produce. Through one field and two lab experiments using two methods to measure implicit beliefs (i.e., the Implicit Association Test and word‐embedding method) and consumer purchases (i.e., actual product choices and a Likert scale), we found that consumers with a high level of incongruence between explicit and implicit “unattractive = natural” beliefs exhibit a greater preference for unattractive produce than those with a low level of such incongruence. This occurs because the incongruence between implicit and explicit beliefs prompts elaborative thinking about the naturalness of unattractive produce, thus alleviating consumer avoidance. Our undertaking contributes to the existing literature on consumer purchase of unattractive produce by examining explicit and implicit beliefs. It also offers valuable insights into leveraging implicit measurement techniques to mitigate food waste.
- Open Access
- 3 June 2020
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 20 (1) , 1-8
Large mid-upper arm circumference is associated with metabolic syndrome in middle-aged and elderly individuals: a community-based study
Background: The mid-upper arm circumference (MUAC) is a proxy for subcutaneous fat in the upper body and is a reliable screening measure for identifying individuals with abnormal regional fat distribution. The purpose of this study was to evaluate the association between MUAC and metabolic syndrome (MetS) in middle-aged and elderly individuals. Methods: We measured the MUAC in a cross-sectional sample with a total of 9787 subjects aged 40 years and older. The measurement of MUAC is performed on the right arm using a non-elastic tape held midway between the acromion and the olecranon processes in duplicate, with the arm hanging loosely at the side of the body. The MetS was defined according to the Joint Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Results: MUAC was positively correlated with waist circumference (r = 0.437, P < 0.001), BMI (r = 0.334, P < 0.001), fasting insulin (r = 0.348, P < 0.001), HOMA-IR (r = 0.134, P < 0.001), triglycerides (r = 0.138, P < 0.001), SBP (r = 0.124, P < 0.001), and DBP (r = 0.123, P < 0.001), and inversely correlated with adiponectin (r = − 0.147, P < 0.001) and HDL-cholesterol (r = − 0.176, P < 0.001) after adjusting for age and gender. Compared with the lowest quartile group, the odds ratios were substantially higher for MetS (OR 1.77; 95% CI 1.51–2.09, P for trend< 0.001) in the highest MUAC quartile group after adjustment for potential cofounder. Conclusion: Large mid-upper arm circumference is significantly associated with metabolic syndrome in middle-aged and elderly individuals.
- 3 June 2020
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 20 (1) , 1-8
Open AccessLarge mid-upper arm circumference is associated with metabolic syndrome in middle-aged and elderly individuals: a community-based study
Background: The mid-upper arm circumference (MUAC) is a proxy for subcutaneous fat in the upper body and is a reliable screening measure for identifying individuals with abnormal regional fat distribution. The purpose of this study was to evaluate the association between MUAC and metabolic syndrome (MetS) in middle-aged and elderly individuals. Methods: We measured the MUAC in a cross-sectional sample with a total of 9787 subjects aged 40 years and older. The measurement of MUAC is performed on the right arm using a non-elastic tape held midway between the acromion and the olecranon processes in duplicate, with the arm hanging loosely at the side of the body. The MetS was defined according to the Joint Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Results: MUAC was positively correlated with waist circumference (r = 0.437, P < 0.001), BMI (r = 0.334, P < 0.001), fasting insulin (r = 0.348, P < 0.001), HOMA-IR (r = 0.134, P < 0.001), triglycerides (r = 0.138, P < 0.001), SBP (r = 0.124, P < 0.001), and DBP (r = 0.123, P < 0.001), and inversely correlated with adiponectin (r = − 0.147, P < 0.001) and HDL-cholesterol (r = − 0.176, P < 0.001) after adjusting for age and gender. Compared with the lowest quartile group, the odds ratios were substantially higher for MetS (OR 1.77; 95% CI 1.51–2.09, P for trend< 0.001) in the highest MUAC quartile group after adjustment for potential cofounder. Conclusion: Large mid-upper arm circumference is significantly associated with metabolic syndrome in middle-aged and elderly individuals.
- Open Access
- 11 August 2015
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 15 (1) , 86
Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes
Osteoprotegerin (OPG) is a member of the tumor necrosis factor receptor superfamily and suggested as a marker of atherosclerosis. However, little is known about the association between plasma OPG levels and lower extremity arterial disease. We investigated whether plasma OPG levels were associated with the presence and severity of lower extremity arterial disease in patients with type 2 diabetes. This was a study of 712 patients with type 2 diabetes aged 40 years or older. Plasma OPG was measured using ELISA. The lower extremity arterial disease was diagnosed by high-frequency color Doppler ultrasonic. Of 712 patients, 505 (70.9 %) had lower extremity arterial stenosis. OPG levels were significantly increased in patients with lower extremity arterial stenosis [1.89 (1.48-2.41) vs. 2.39 (1.82-3.33) ng/mL, p < 0.001]. Plasma OPG levels increased gradually with increasing severity of lower extremity arterial stenosis (p < 0.001 for trend), after adjustment for traditional cardiovascular risk factors such as age, gender, smoking, total cholesterol, high-density lipoprotein (HDL) cholesterol, C-reactive protein (CRP), body mass index (BMI), systolic blood pressure(SBP). The risk of lower extremity arterial disease was increased (OR = 1.17, 95 % CI 1.09 –1.28, p < 0.001) with each standard deviation (SD) higher level of OPG in patients with type 2 diabetes after adjustment for traditional CVD risk factors. Plasma OPG levels were significantly associated with the presence and severity of lower extremity arterial disease. Our results suggest that OPG is an important plasma biomarker of lower extremity arterial disease in type 2 diabetes.
- 11 August 2015
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 15 (1) , 86
Open AccessAssociation of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes
Osteoprotegerin (OPG) is a member of the tumor necrosis factor receptor superfamily and suggested as a marker of atherosclerosis. However, little is known about the association between plasma OPG levels and lower extremity arterial disease. We investigated whether plasma OPG levels were associated with the presence and severity of lower extremity arterial disease in patients with type 2 diabetes. This was a study of 712 patients with type 2 diabetes aged 40 years or older. Plasma OPG was measured using ELISA. The lower extremity arterial disease was diagnosed by high-frequency color Doppler ultrasonic. Of 712 patients, 505 (70.9 %) had lower extremity arterial stenosis. OPG levels were significantly increased in patients with lower extremity arterial stenosis [1.89 (1.48-2.41) vs. 2.39 (1.82-3.33) ng/mL, p < 0.001]. Plasma OPG levels increased gradually with increasing severity of lower extremity arterial stenosis (p < 0.001 for trend), after adjustment for traditional cardiovascular risk factors such as age, gender, smoking, total cholesterol, high-density lipoprotein (HDL) cholesterol, C-reactive protein (CRP), body mass index (BMI), systolic blood pressure(SBP). The risk of lower extremity arterial disease was increased (OR = 1.17, 95 % CI 1.09 –1.28, p < 0.001) with each standard deviation (SD) higher level of OPG in patients with type 2 diabetes after adjustment for traditional CVD risk factors. Plasma OPG levels were significantly associated with the presence and severity of lower extremity arterial disease. Our results suggest that OPG is an important plasma biomarker of lower extremity arterial disease in type 2 diabetes.